Current extractable and leachable requirements for infusion systems discussed

In light of the recent introduction of the draft 510K guideline for infusion pumps by the FDA, the direction for extractable and leachable activities for infusion systems will be discussed at Pira’s Extractables and Leachables (E&L) 2011 conference
Spread the Word
Listed Under

* Extractable

* Medical
* Business
* Science

* Leatherhead - Surrey - UK

Nov. 1, 2011 - PRLog -- During the opening of last year’s E&L conference, the co-chairs, Dr Carsten Worsoe, Research Scientist at Novo Nordisk, and Thomas Egert, Chemical Characterisation, Drug Delivery Department at Boehringer Ingelheim Pharma, revealed their thoughts on the progression of extractable and leachable related areas in the future. Two areas predicted as being of high E&L interest were PODPs (Parenteral and Ophthalmic Drug Products) and administrations systems.

With the "Safety Assessment Triad" for PODPs introduced by the PQRI (Product Quality Research Institute) group, the term simulated study was initiated in order to close the gap between extractables and leachables. Presentations featuring simulated studies for both parenterals and ophthalmic will be one of the main topics at this year’s E&L conference. Following the introduction of the draft 510K guideline for infusion pumps by the FDA, describing E&L activities both for pump suppliers and pharmaceutical companies applying drugs for pump use, a direction for E&L activities for infusion systems has also been given.

In addition to discussing this key topic, the conference will also deal with several other E&L related areas such as SUS (Single Use Systems), supply chain challenges, innovation of materials based on E&L knowledge, the role of CRO laboratories and actual E&L strategies for pharmaceutical companies including several case studies as well as health authority expectations.

Pira International’s 5th annual Extractables and Leachables conference is due to take place on 7-8 December 2011 in Rome, Italy and will be chaired by industry experts Dr Carsten Worsoe of Novo Nordisk and Thomas Egert of Boehringer Ingelheim Pharma.

Dr Carsten Worsoe expressed the following in anticipation of the event: “I feel that depth in the coverage of E&L areas is one of the strengths of this conference and that the conference applies directly to people that are both new to the E&L area as well as to people with high experience.”

For more information visit or to enquire about the availability of a press pass contact Daniel Trillo, Pira International, +44 (0)1372 802101,


About Pira International
Pira International is the worldwide authority on the packaging, paper and print industry supply chains. Established in 1930, Pira provides strategic and technical consulting, testing, intelligence and events to help clients gain market insights, identify opportunities, evaluate product performance and manage compliance.
Email:*** Email Verified
Industry:Medical, Business, Science
Location:Leatherhead - Surrey - United Kingdom
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Pira International News
Daily News
Weekly News

Like PRLog?
Click to Share